SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 240 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $5,788,000 | -41.1% | 50,358 | -19.9% | 0.35% | -48.8% |
| Q3 2014 | $9,824,000 | +7.8% | 62,878 | -14.9% | 0.68% | +11.7% |
| Q2 2014 | $9,112,000 | -14.9% | 73,873 | -28.5% | 0.61% | -22.0% |
| Q1 2014 | $10,704,000 | +18.6% | 103,315 | +2.9% | 0.79% | +20.7% |
| Q4 2013 | $9,028,000 | +74.4% | 100,382 | +29.7% | 0.65% | +31.0% |
| Q3 2013 | $5,178,000 | -28.4% | 77,421 | -29.2% | 0.50% | -30.4% |
| Q2 2013 | $7,235,000 | – | 109,366 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
| OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
| SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
| Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
| Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
| HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
| CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
| Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |